SHARPE
Reported results
- Net sales from continuing operations were $645 million.
- Net income from continuing operations was $85 million, or $2.13 per diluted share.
- Non-GAAP adjusted operating earnings from continuing operations were $53 million, or $1.33 per diluted share.
- Non-GAAP adjusted EBITDA from continuing operations was $128 million, with a non-GAAP adjusted EBITDA margin of 20%.
- Cash provided by operating activities from continuing operations was $70 million.
- Non-GAAP free cash flow was $16 million.
Guidance
- The paper machine optimization project will add an additional 60,000 short tons of uncoated freesheet capacity annually.
- A new state-of-the-art sheeter will add approximately 200,000 short tons of cutsize converting capacity, with startup expected early in the third quarter of 2027.
Notes
Sylvamo’s Europe business is now reported as discontinued operations, and prior periods have been recast to present continuing operations excluding Europe.
Price and volatility reaction
The stock moved +19.1% on the print. No front-expiry chain was on file, so there is no straddle expected move.
| Measure | Value | Basis |
|---|---|---|
| Close before release | 33.07 | 2026-11-05 |
| Close after release | 39.38 | 2026-11-06 |
| Realised move | +19.1% | close to close |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-06 (8-K, Item 2.02). Read the original filing on sec.gov.